Analisis Risiko Potensi Kegagalan Proses Penjernihan Air Limbah Industri Farmasi Dengan Pendekatan Metode AHP

Dino Rimantho

DOI: https://doi.org/10.23917/jiti.v18i1.7776

Abstract

The pharmaceutical industry has the potential to produce waste water which is categorized as hazardous waste. The operational process of waste treatment has the potential to pose a risk of processing failure. The purpose of this article is to analyze the risks that occur in the pharmaceutical industry wastewater treatment process. This study uses the Analytichal Hierarchy Process (AHP) method. The number of experts used was three people. The results show that there are four main factors that have the potential to produce a risk of failure of wastewater treatment processes such as man, machinery, method, and material. The method factor is the highest risk factor which is around 0.609 with a consistency ratio of 0.08. In addition, the Sub-criteria that have the potential to experience the risk of process failure are the Standard Operational Procedure (SOP) which has not run optimally which is equal to 0.701. Furthermore, in assessing the level of risk obtained, the optimal SOP is run at 0.685. The implication of the application of the AHP method is that a more in-depth review is needed regarding the criteria and sub-criteria used to obtain more comprehensive results.

Keywords

waste water; AHP; pharmaceutical industry; process failure; risk

Full Text:

PDF

References

Aminbakhsh, S.; Gunduz, M.; Sonmez, R. (2013). “Safety risk assessment using analytic hierarchy process (AHP) during planning and budgeting of construction projects”. Journal of Safety Research, 46, 99–105.

Angelakis, A.N.; Snyder, S.A. (2015). “Wastewater Treatment and Reuse: Past, Present, and Future”. Water, 7 (9), 4887-4895. doi:10.3390/w7094887

Aziz, J.A.; Tebbutt, T.H.Y. (1980). “Significance of COD, BOD and TOC correlations in kinetic models of biological oxidation”. Water Research, 14 (4), 319.

Barton, T.; Shenkir, W.; Walker, P. (2002). Making Enterprise Risk Management Pay Off: How Leading Companies Implement Risk Management. Financial Times Prentice Hall.

Carballa, M.; Omil F.; Lema, J.M. (2005). “Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment”, Water Research, 39 (17), 4790–4796.

Clara, M.; Strenn, B.; Gans, O.; Martinez, E.; Kreuzinger, N.; Kroiss, H. (2005). “Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in membrane bioreactor and conventional wastewater treatment plants”. Water Research, 39 (19), 4797–4807.

Danumah, J.H.; Odai, S.N.; Saley, B.M.; Szarzynski, J.; Thiel, M.; Kwaku, A.; Kouame, F.K.; Akpa, L.Y. (2016). “Flood risk assessment and mapping in Abidjan district using multi-criteria analysis (AHP) model and geoinformation techniques, (cote d’ivoire)”. Geoenvironmental Disasters, 3 (10), 1-13.

Hirata A.; Nakamura Y.; Tsuneda S. (2001). “Biological nitrogen removal from industrial wastewater discharged from metal recovery processes”. Water Science and Technology, 44 (2–3), 171–179.

Hong, X.; Xiaoliang, C.; Cilan, Z. (2014). “The Risk Analysis and Evaluation of Urban Underground Logistics System Development Based on the Grey Analytic Hierarchy Process”. The Open Mechanical Engineering Journal, 8, 354-357.

Huber, M.M.; Gobel A.; Joss A.; Hermann N.; Loffler D.; McArdell, C.S.; Ried, A.; Siegrist, H.; Ternes, T.A.; von Gunten, U. (2005). “Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study”. Environmental Science and Technology, 39 (11), 4290–4299.

Jaberidoost, M.; Olfat, L.; Hosseini, A.; Kebriaeezadeh. A.; Abdollahi, M.; Alaeddini, M.; Dinarvand, R. (2015). “Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods”. Journal of Pharmaceutical Policy and Practice, 8 (9), 1-10.

Joss, A.; Zabczynski, S.; Göbel, A.; Hoffmann, B.; Löffler, D.; McArdell, C.S.; Ternes, T.A.; Thomsen, A.; Siegrist, H. (2006). “Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification scheme”. Water Research, 40 (8), 168-169.

Khodadadi, S.A.T.; Kumar, D. (2013), “Contractor selection with risk assessment by using AHP fuzzy method”. International Journal of Advances in Engineering & Technology, 5 (2), 311-318.

Kimura, K.; Hara, H.; Watanabe, Y. (2005). “Removal of pharmaceutical compounds by submerged membrane bioreactors (MBR)”. Desalination, 178 (1–3), 135–140.

Malandra, L.; Wolfaardt, G.; Zietsman, A.; Viljoenbloom, M. (2003). “Microbiology of a biological contactor for winery wastewater treatment”. Water Research, 37 (17), 4125-4134.

Metcalf, L.; Eddy, H.P. (2003). Handbook of Wastewater Engineering – Treatment and Reuse, 4th Ed., New York: McGraw Hill.

Paranychianakis, N.V.; Salgot, M.; Snyder, S.A.; Angelakis, A.N. (2015). “Quality criteria for recycled wastewater effluent in EU-countries: Need for a uniform approach”. Crit. Rev. Environ. Sci. Technol., 45, 1409–1468.

Sim, W.J.; Lee, J.W.; Oh, J.E. (2010). “Occurrence and fate of pharmaceuticals in wastewater treatment plants and rivers in Korea”. Environmental Pollution, 158 (5), 1938-1947.

Stackelberg, P.E.; Furlong, E.T.; Meyer, M.T.; Zaugg, S.D.; Henderson, A.; Reissman, D.B. (2004). “Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking water treatment plant”. Journal Science of the total environment, 329 (1-3), 99-113.

USEPA (1991), Guilds to Pollution Prevention: The Pharmaceutical Industry. EPA/625/7-91/017. U.S Environmental Protection Agency. 1991.

Wing, A.C.K.; Mohammed, A.H.; Abdullah, M.N. (2016), “A Review of Maintenance Priority Setting Methods”. International Journal of Real Estate Studies, 10 (2), 1-9.

Article Metrics

Abstract view(s): 477 time(s)
PDF: 546 time(s)

Refbacks

  • There are currently no refbacks.